News

Adaptation to food deprivation as a clue for treating metabolic diseases
30 September 2016
When people are deprived of food, a number of biological mechanisms are set in motion to adapt the body’s metabolism to the conditions of scarcity. One of these processes has been revealed by a team of Belgian researchers, led by Karolien De Bosscher
Where You Live Shapes Your Immune System More than Your Genes
29 September 2016
In a Review published September 29 in Trends in Immunology, three immunologists discuss the emerging science of what shapes our immune systems and how it might be applied.
Meet the 8 most used experimental subjects at VIB
28 September 2016
Each science field or research scope requires the best-fitting model, and each one comes with perks and limitations. Let’s take a microscopic look at the most common lifeforms VIB scientists are using to contribute to better lives.
Scientists track down possible new treatment for epilepsy
26 September 2016
Increasing the concentration of specific fats in the brain could suppress epileptic seizures. This is evident from ground-breaking research carried out by groups of Patrik Verstreken (VIB-KU Leuven) and Wim Versées (VIB-Vrije Universiteit Brussel).
Researchers take a new step towards non-antibiotic bladder infection therapies
23 September 2016
A team of scientists has gained fresh insight into the development of bladder infections, also known as cystitis. These findings are the result of VIB-VUB researchers & their American colleagues at the center for Women’s Infectious Disease Research.
Macrophages: one of the oldest immune cells reveals its hidden beauty after a century
20 September 2016
We are in 2016, an important year for macrophages (and macrophage researchers). It has been 100 years since the death of Elie Metchnikoff who discovered macrophages: the ideal opportunity to focus on macrophage research within VIB.
Belgian rheumatology researchers are among Europe’s finest
19 September 2016
For the third time in a row, an alliance of Ghent-based researchers & clinicians has been awarded the label EULAR Center of Excellence. This European institute fosters excellence in education and research in the field of rheumatology.
Quickscan scientific topics 2016
18 September 2016
Quickscan scientific publications
Former Janssen topman, Ajit Shetty, is named chairperson of the VIB board of directors
15 September 2016
Dr Ajit Shetty, the former CEO of Janssen Pharmaceutica, has been named the new chairperson for the board of directors at VIB. Shetty succeeds Dr Staf Van Reet in the role.
Belgian scientists discover missing link in septic shock
14 September 2016
VIB & Ghent University Researchers discovered important mechanism of sepsis, an overreaction of the body’s immune system to an infection. In this condition, the brain is unable to curb an inflammatory response, causing organ failure or ‘septic shock’.
ERC Starting Grant for VIB researcher Bert De Rybel
9 September 2016
The European Commission awards Dr. Bert De Rybel (VIB-UGent) with a ERC starting grant. This grant, almost €1.5 million over 5 years, is one of the most prestigious grants for young researchers in the European Union.
Beer yeasts are dogs, wine yeasts are cats
8 September 2016
Researchers from VIB, KU Leuven and Ghent University found that yeasts used for beer and winemaking have been domesticated in the 16th century, around 100 years before the discovery of microbes.
VIB team develops groundbreaking membrane analysis tool
7 September 2016
To understand the complexity of cell membranes, scientists count on a panoply of technological tools that allow them to analyze microscopic images. A multidisciplinary team from VIB-KU Leuven has just added an important one to the list: ‘QuASIMoDOH’ is
Technology Watch For Synthetic Biology: Towards The $1,000 Synthetic Genome
5 September 2016
VIB’s Tech Watch has boosted many projects by enabling access to cheap synthetic DNA and in this text we highlight some examples showing how VIB scientists have adopted these technologies.
BioPontis Alliance for Rare Diseases and VIB announce strategic partnership on rare diseases - First project on Charcot-Marie-Tooth Disease
2 September 2016
Today, BioPontis Alliance for Rare Diseases, a unique international nonprofit organization, and VIB, an excellence-based Life Science Research Institute in Belgium, announced a strategic partnership in rare diseases.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS